Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Patent Reform Bill Markup Delayed In Senate By Damages Debate

This article was originally published in The Gray Sheet

Executive Summary

Patent reform legislation continues to be contentious in the Senate, where it was again delayed last week over differences of on how to deal with infringement damage calculations

You may also be interested in...



Feinstein Backs Off Codifying Georgia-Pacific Factors In Patent Bill

A key Senate supporter of patent reform says she is giving some ground on how infringement damage calculations can be dealt with in legislation

Feinstein Backs Off Codifying Georgia-Pacific Factors In Patent Bill

A key Senate supporter of patent reform says she is giving some ground on how infringement damage calculations can be dealt with in legislation

Senators Willing To Negotiate On Patent Reform Bill Damage Provisions

Lawmakers say they are willing to negotiate controversial provisions on infringement damage awards included in the latest versions of House and Senate patent reform bills

Related Content

Topics

UsernamePublicRestriction

Register

MT027244

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel